Dr. Montazeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-724-4000
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2017
Iran University of Medical SciencesClass of 2009
Mount Auburn HospitalResidency, Internal Medicine
Certifications & Licensure
MA State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma Start of enrollment: 2021 Aug 02
Roles: Contact, Principal Investigator
- IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma Start of enrollment: 2023 Oct 31
Roles: Contact
Publications & Presentations
PubMed
- Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 2023.Rino S Seedor, Andrew E Aplin, Corine Bertolotto, Richard D Carvajal, Nigel Deacon
Pigment Cell & Melanoma Research. 2024-10-09 - 2 citationsTofacitinib is Effective in Treating Refractory Immune Checkpoint Inhibitor Hepatitis.Mike Wang, Kerry L Reynolds, Kamaneh Montazeri, Esperance A Schaefer, Ryan J Sullivan
Clinical Gastroenterology and Hepatology. 2024-07-01 - 1 citationsDetection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.Takuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, Anne Marie Lane, Mary Beth Aronow
JCO Precision Oncology. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
